Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue

Overview of attention for article published in Journal of Hepatology, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 6,397)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 40 news stories from 35 outlets.

A svédországi Karolinska Institutet kutatói a Journal of Hepatology folyóiratban publikálták új vizsgálatuk eredményét, mely…

Solna, February 11: There is currently no medication available to treat non-alcoholic liver disease, which affects many type 2…

Solna [Sweden]: There is currently no medication available to treat non-alcoholic liver disease, which affects many type 2…

There is currently no medication available to treat non-alcoholic liver disease which affects many type 2 diabetes patients and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 36 additional news stories.